"We must take action now, by permitting re-importation, to ensure that health care and prescription drugs remain accessible and affordable for everyone"
About this Quote
Urgency is doing a lot of political work here. “We must take action now” isn’t just a call to policy; it’s a bid to seize the moral high ground before anyone can ask the uncomfortable questions about trade-offs, industry backlash, or regulatory risk. Michael K. Simpson frames “permitting re-importation” as the obvious lever - a technical tweak with populist optics - while skipping the messy reality that drug pricing is a maze of patents, PBMs, insurance design, and negotiated rebates. The genius of the line is that it offers a villain (high prices) and a simple-seeming fix (import the same drugs from cheaper markets), letting the listener feel both pragmatic and righteous.
“Permitting” is especially telling. It casts government as a gatekeeper currently blocking relief, implying that affordability is being withheld by policy choice rather than structural incentives. That subtly redirects anger away from Congress’s long history of half-measures and toward an easier target: bureaucracy and “the system.” The phrase “remain accessible and affordable for everyone” widens the circle to a universal constituency, but it also blurs who benefits most - seniors on fixed incomes, chronically ill patients, the uninsured - into a single “everyone” that’s hard to oppose and easy to campaign on.
The context for this kind of rhetoric is predictable: public outrage over drug costs, election-cycle pressure, and bipartisan appetite for a consumer-friendly reform that sounds tougher than it is. Re-importation becomes a symbolic battering ram against pharmaceutical pricing power - whether or not it can carry the whole fight.
“Permitting” is especially telling. It casts government as a gatekeeper currently blocking relief, implying that affordability is being withheld by policy choice rather than structural incentives. That subtly redirects anger away from Congress’s long history of half-measures and toward an easier target: bureaucracy and “the system.” The phrase “remain accessible and affordable for everyone” widens the circle to a universal constituency, but it also blurs who benefits most - seniors on fixed incomes, chronically ill patients, the uninsured - into a single “everyone” that’s hard to oppose and easy to campaign on.
The context for this kind of rhetoric is predictable: public outrage over drug costs, election-cycle pressure, and bipartisan appetite for a consumer-friendly reform that sounds tougher than it is. Re-importation becomes a symbolic battering ram against pharmaceutical pricing power - whether or not it can carry the whole fight.
Quote Details
| Topic | Health |
|---|
More Quotes by Michael
Add to List
